Zhao ZJ - Search Results

1

ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis.

Guo Y, Zhou Y, Yamatomo S, Yang H, Zhang P, Chen S, Nimer SD, Zhao ZJ, Xu M, Bai J, Yang FC. Guo Y, et al. Among authors: zhao zj. Leukemia. 2019 May;33(5):1287-1291. doi: 10.1038/s41375-018-0347-y. Epub 2019 Jan 16. Leukemia. 2019. PMID: 30651633 No abstract available.

2

SPAP2, an Ig family receptor containing both ITIMs and ITAMs.

Xu MJ, Zhao R, Cao H, Zhao ZJ. Xu MJ, et al. Among authors: zhao r, zhao zj. Biochem Biophys Res Commun. 2002 May 10;293(3):1037-46. doi: 10.1016/S0006-291X(02)00332-7. Biochem Biophys Res Commun. 2002. PMID: 12051764

3

Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth.

Li Z, Xu M, Xing S, Ho WT, Ishii T, Li Q, Fu X, Zhao ZJ. Li Z, et al. Among authors: zhao zj. J Biol Chem. 2007 Feb 9;282(6):3428-32. doi: 10.1074/jbc.C600277200. Epub 2006 Dec 18. J Biol Chem. 2007. PMID: 17178722 Free PMC article.

4

Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice.

Xing S, Wanting TH, Zhao W, Ma J, Wang S, Xu X, Li Q, Fu X, Xu M, Zhao ZJ. Xing S, et al. Among authors: zhao w, zhao zj. Blood. 2008 May 15;111(10):5109-17. doi: 10.1182/blood-2007-05-091579. Epub 2008 Mar 11. Blood. 2008. PMID: 18334677 Free PMC article.

5

Development of a highly sensitive method for detection of JAK2V617F.

Zhao AH, Gao R, Zhao ZJ. Zhao AH, et al. Among authors: zhao zj. J Hematol Oncol. 2011 Oct 10;4:40. doi: 10.1186/1756-8722-4-40. J Hematol Oncol. 2011. PMID: 21985400 Free PMC article.

6

Identification of an orally available compound with potent and broad FLT3 inhibition activity.

Chen Y, Guo Y, Zhao W, Tina Ho WT, Fu X, Zhao ZJ. Chen Y, et al. Among authors: zhao w, zhao zj. Oncogene. 2016 Jun 9;35(23):2971-8. doi: 10.1038/onc.2015.362. Epub 2015 Sep 28. Oncogene. 2016. PMID: 26411368 Free PMC article.

7

Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia.

Chen Y, Pan Y, Guo Y, Zhao W, Ho WT, Wang J, Xu M, Yang FC, Zhao ZJ. Chen Y, et al. Among authors: zhao w, zhao zj. Stem Cell Investig. 2017 Jun 2;4:48. doi: 10.21037/sci.2017.05.04. eCollection 2017. Stem Cell Investig. 2017. PMID: 28607922 Free PMC article. Review.

8

Tyrosine phosphatases SHP-1 and SHP-2 are associated with distinct tyrosine-phosphorylated proteins.

Xu F, Xu MJ, Zhao R, Guerrah A, Zeng F, Zhao ZJ. Xu F, et al. Among authors: zhao r, zhao zj. Exp Cell Res. 2002 Jan 1;272(1):75-83. doi: 10.1006/excr.2001.5397. Exp Cell Res. 2002. PMID: 11740867

9

PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.

Xu MJ, Sui X, Zhao R, Dai C, Krantz SB, Zhao ZJ. Xu MJ, et al. Among authors: zhao r, zhao zj. Blood. 2003 Dec 15;102(13):4354-60. doi: 10.1182/blood-2003-04-1308. Epub 2003 Aug 14. Blood. 2003. PMID: 12920026 Free article.

10

Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis.

Sutton BC, Allen RA, Zhao ZJ, Dunn ST. Sutton BC, et al. Among authors: zhao zj. Cancer Biomark. 2007;3(6):315-24. doi: 10.3233/cbm-2007-3605. Cancer Biomark. 2007. PMID: 18048969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page